Latest News about FDA
Recent news which mentions FDA
After One Year Of Regulatory Hold, Larimar's Ataxia Candidate Sees Some Hope
September 14, 2022
Tickers
LRMR
From Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
From Benzinga
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
September 13, 2022
Tickers
GNFT
From Benzinga
Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System
September 13, 2022
Tickers
CFMS
From Benzinga
Syros Shares Soar As FDA Grants Orphan Drug Status To Pancreatic Cancer Candidate
September 13, 2022
Tickers
SYRS
From Benzinga
FDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing Loss
September 13, 2022
Tickers
AKUS
From Benzinga
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate
September 13, 2022
Tickers
LIFE
From Benzinga
FDA Schedules AdComm Review For First Over The Counter Birth Control Pill
September 13, 2022
Tickers
PRGO
From Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial
September 12, 2022
Tickers
BMRN
From Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
From Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022
September 09, 2022
Tickers
SPPI
From Benzinga
U.S. FDA And European Medicines Agency Accepted Pfizer's Hair Loss Candidate Submission For Review
September 09, 2022
Tickers
PFE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.